In this Deep Dive Session, Prof. Pier Luigi Zinzani, from the University of Bologna, discusses the use of PD-1 inhibitors in the treatment of relapsed or refractory Hodgkin’s lymphoma. He presents data from various studies, including his own, highlighting the effectiveness of these inhibitors and the potential for their use in combination with other treatments, such as allogeneic stem cell transplantation.
27-06-2022 Relapsed Refractory Hodgkin Lymphoma management
See more from BLOODSA
BMT Classroom
October 2, 2024
Haem Deep Dive
30-09-2024 Essential Insights Gained on Emicizumab: Navigating Surgery and Comorbidities
Timestamps:
September 30, 2024